Charmeil named Sanofi vaccines head

Sanofi-Aventis has named Olivier Charmeil as its new senior VP of vaccines. Charmeil previously covered the Asia-Pacific and Japan regions in the company's pharmaceutical division, which Sanofi CEO Christopher Viehbacher says is an asset to vaccines, as it focuses on emerging markets. The leadership change will occur Jan. 1, as Wayne Pisano steps down. Sanofi release | Article

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.